Why it is important to continue antibacterial drug discovery

被引：0

|

作者：

Bush, K ^{[1
]}

机构：

[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Antimicrobial Agents Drug Discovery, Raritan, NJ USA

来源：

ASM NEWS | 2004年 / 70卷 / 06期

关键词：

D O I：

暂无

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Combating resistance, improving safety, and preserving R&D teams are among reasons for persevering.

引用

收藏

页码：282 / 287

页数：6

相关论文

共 50 条

[1] Why traditional knowledge is important in drug discovery
Dutfield, Graham
FUTURE MEDICINAL CHEMISTRY, 2010, 2 (09) : 1405 - 1409
[2] Why is big Pharma getting out of antibacterial drug discovery?
Projan, SJ
CURRENT OPINION IN MICROBIOLOGY, 2003, 6 (05) : 427 - 430
[3] Antibacterial drug discovery
VanBogelen, Ruth A.
Brzezinski, Erin E.
MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (10) : S159 - S159
[4] Antibacterial and antifungal drug discovery
Aris Persidis
Nature Biotechnology, 1999, 17 : 1141 - 1142
[5] Challenges of antibacterial drug discovery
Reck, Folkert
Jansen, Johanna M.
Moser, Heinz E.
ARKIVOC, 2019, : 227 - 244
[6] Antibacterial and Antifungal Drug Discovery
不详
Nature Biotechnology, 2000, 18 (Suppl 10) : IT24 - IT26
[7] Whither antibacterial drug discovery?
Projan, Steven J.
DRUG DISCOVERY TODAY, 2008, 13 (7-8) : 279 - 280
[8] Antibacterial and antifungal drug discovery
Persidis, A
NATURE BIOTECHNOLOGY, 1999, 17 (11) : 1141 - 1142
[9] Functional genomics in antibacterial drug discovery
Freiberg, C
Brötz-Oesterhelt, H
DRUG DISCOVERY TODAY, 2005, 10 (13) : 927 - 935
[10] Genetic strategies for antibacterial drug discovery
Miesel, L
Greene, J
Black, TA
NATURE REVIEWS GENETICS, 2003, 4 (06) : 442 - 456

← 1 2 3 4 5 →